EnzyTag has been set up as spin-out of EnzyPep BV

EnzyTag will continue the development of chemo-enzymatic procedures for manufacturing peptide-based NCEs and bioconjugates using EnzyPep’s proprietary peptiligase technology.  EnzyTag has an exclusive, world-wide and perpetual license to the technology.

2019-02-01T18:17:36+00:00
We use cookies to ensure that our website runs as smoothly as possible and to analyze web traffic. If you continue to use the website, you agree with our Privacy Policy. I agree